Self-experimentation in medicine 18th century. There was an unsuccessful campaign to award a Nobel Prize to Reed's team. Lazear, in any event, could not be awarded the prize because it is never given posthumously. However, a Nobel Prize was awarded to a later yellow fever researcher and self-experimenter, Max Theiler who, in 1951, developed the first yellow fever vaccine and was the first to try it. Anatolii Al'bertovich Shatkin, in 1961, injected trachoma virus into the conjunctival sac of his eye and rapidly developed trachoma. He did not begin treatment of the condition for 26 days. In July 1944, physician researcher Claude Barlow
Schistosomiasis vaccine Schistosomiasis vaccine A Schistosomiasis vaccine is a vaccine against Schistosomiasis (also known as bilharzia, bilharziosis or snail fever), a parasitic disease caused by several species of fluke of the genus "Schistosoma". No effective vaccine for the disease exists yet. Schistosomiasis affects over 200 million people worldwide, mainly in rural agricultural and peri-urban areas of developing countries, and approximately 10% suffer severe health complications from the infection. While chemotherepeutic drugs, such as praziquantel, oxamniquine and metrifonate both no longer on the market, are currently considered safe and effective for the treatment of schistosomiasis, reinfection occurs frequently following drug treatment, thus a